ViaCyte Inc., a privately held regenerative medicine company, has been awarded a $20 million grant from the California Institute for Regenerative Medicine (CIRM) to support the clinical development of its PEC-Direct™ product candidate. This novel cell replacement therapy is being developed
You are here
Coverage of the latest news and updates from the field of stem cells.
A chemical tag added to RNA during embryonic development regulates how the early brain grows, according to research from the Perelman School of Medicine at the University of Pennsylvania.
Heart disease continues to be the leading cause of death worldwide, partly due to limited therapeutic options and the heart’s inability to regenerate healthy cells called cardiomyocytes after heart attacks.
The plant Ambrosia arborescens grows wild in much of South America and is traditionally used as a medicinal plant. Researchers at the Faculty of Science at Lund University, in collaboration with colleagues in La Paz, Bolivia, have isolated the substance damsin from the pla
As the embryonic brain develops an incredibly complex cascade of cellular events occur, starting with progenitors — the originating cells that generate neurons and spur proper cortex development.
The answer to regenerative medicine's most compelling question —why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot — may lie with the body's innate immune system, according to a new study of heart regeneration in the axolotl, or M
In the future people with diabetes might benefit from getting insulin-regulating beta cells transplanted into their body because their own beta cells are destroyed or less functional.
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial.
Researchers have detailed an underlying mechanism that leads to a major health problem for older people, osteoporosis. When this mechanism malfunctions, progenitor cells stop creating bone-producing cells and instead create fat cells.
Scientists from the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg and the Freiburg University Medical Center have shown that inhibiting the epigenetic regulator KDM4 might offer a potential novel treatment option for breast cancer patients.